Skip to main content
. 2021 Mar 12;2021(3):CD013316. doi: 10.1002/14651858.CD013316.pub2

Bady 2012 (E‐GBM).

Study characteristics
Study design Cohort
Study setting Setting: Neurosurgery Departments of Rennes and Angers University Hospitals
Country: France
Dates: NR
Selection of participants Cases from an external dataset (Etcheverry 2010). Prospectively collected samples from people with newly diagnosed GBM
Participant characteristics Sample size: 50 (deaths: NR)
Age: median 57.5, SD NR; range 26–80 years
Sex: 51% men
KPS: median 78.6; range 40–100
Tumour characteristics GBM: 100%
First diagnosis: 100%
Biopsy: NR; subtotal resection: NR; total resection: NR
IDH1 wild‐type: NR; IDH2 wild‐type: NR
Treatment regimen Stupp protocol
MGMT promoter methylation tests implemented PSQ, bead array
Dates and follow‐up Timing of MGMT assessment: at diagnosis
Start time for follow‐up: NR; follow‐up: median NR; range NR
Notes